Stay updated on RO6874281 for HER2-positive Cancer: Clinical Trial

Sign up to get notified when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the RO6874281 for HER2-positive Cancer: Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    5%
    Check dated 2025-02-24T18:24:38.000Z thumbnail image
  5. Check
    30 days ago
    No Change Detected
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.
    Difference
    5%
    Check dated 2025-02-10T09:22:35.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.3%
    Check dated 2025-02-03T05:06:54.000Z thumbnail image
  8. Check
    58 days ago
    Change Detected
    Summary
    The website has been updated from version 2.14.0 to 2.14.1.
    Difference
    0.3%
    Check dated 2025-01-19T19:25:53.000Z thumbnail image
  9. Check
    65 days ago
    Change Detected
    Summary
    The type of intervention has been updated from version v2.13.3 to v2.14.0.
    Difference
    1.0%
    Check dated 2025-01-12T15:58:42.000Z thumbnail image
  10. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.13.2 to v2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T12:13:26.000Z thumbnail image

Stay in the know with updates to RO6874281 for HER2-positive Cancer: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the RO6874281 for HER2-positive Cancer: Clinical Trial page.